Clinical Trial

Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 19, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 months postoperatively and the patency will be evaluated with coronary computed tomography angiography (CCTA)
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-03-02; most recent amendment 2025-12-14.
Status change: Enrolling by Invitation → Recruiting 2025-12-14
Status change: Recruiting → Enrolling by Invitation 2023-01-18
Status change: Not Yet Recruiting → Recruiting 2021-05-24
Trial Details
NCT Number NCT04783701
Lead Sponsor University Hospital, Linkoeping
Conditions Acute Coronary Syndrome, Coronary Bypass Stenosis
Enrollment 360 participants
Start Date 2021-05-17
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-03-15 (estimated)
Updated on ClinicalTrials.gov 2025-12-19